Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 8
1964 17
1965 3
1966 1
1967 9
1968 4
1969 13
1970 16
1971 19
1972 26
1973 22
1974 20
1975 27
1976 32
1977 23
1978 23
1979 36
1980 30
1981 32
1982 32
1983 36
1984 43
1985 52
1986 56
1987 97
1988 133
1989 214
1990 241
1991 222
1992 241
1993 269
1994 255
1995 276
1996 285
1997 342
1998 311
1999 313
2000 311
2001 395
2002 413
2003 464
2004 519
2005 510
2006 547
2007 609
2008 613
2009 632
2010 643
2011 649
2012 689
2013 762
2014 750
2015 787
2016 803
2017 839
2018 754
2019 693
2020 780
2021 692
2022 694
2023 738
2024 155

Text availability

Article attribute

Article type

Publication date

Search Results

17,732 results

Results by year

Filters applied: . Clear all
Page 1
Imaging Characterization of Renal Masses.
Nicolau C, Antunes N, Paño B, Sebastia C. Nicolau C, et al. Medicina (Kaunas). 2021 Jan 8;57(1):51. doi: 10.3390/medicina57010051. Medicina (Kaunas). 2021. PMID: 33435540 Free PMC article. Review.
The detection of a renal mass is a relatively frequent occurrence in the daily practice of any Radiology Department. ...The approach to well-defined lesions focuses mainly on the differentiation between renal cancer and benign tumors such as angiomyolipoma (A …
The detection of a renal mass is a relatively frequent occurrence in the daily practice of any Radiology Department. ...The approach …
The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.
Moch H, Amin MB, Berney DM, Compérat EM, Gill AJ, Hartmann A, Menon S, Raspollini MR, Rubin MA, Srigley JR, Hoon Tan P, Tickoo SK, Tsuzuki T, Turajlic S, Cree I, Netto GJ. Moch H, et al. Eur Urol. 2022 Nov;82(5):458-468. doi: 10.1016/j.eururo.2022.06.016. Epub 2022 Jul 16. Eur Urol. 2022. PMID: 35853783 Free article. Review.
Such novel molecularly defined epithelial renal tumours include SMARCB1-deficient medullary renal cell carcinoma (RCC), TFEB-altered RCC, Alk-rearranged RCC, and ELOC-mutated RCC. ...Nomenclature changes include replacement of the term "primitive neuroectoder …
Such novel molecularly defined epithelial renal tumours include SMARCB1-deficient medullary renal cell carcinoma (RCC), …
Clear cell renal cell carcinoma ontogeny and mechanisms of lethality.
Jonasch E, Walker CL, Rathmell WK. Jonasch E, et al. Nat Rev Nephrol. 2021 Apr;17(4):245-261. doi: 10.1038/s41581-020-00359-2. Epub 2020 Nov 3. Nat Rev Nephrol. 2021. PMID: 33144689 Free PMC article. Review.
The TRACERx Renal studies and others that have described the interaction between tumour genomics and remodelling of the tumour microenvironment provide important new insights into the molecular drivers underlying ccRCC ontogeny and progression. ...Considerati …
The TRACERx Renal studies and others that have described the interaction between tumour genomics and remodelling of the tum
Tumour lysis syndrome.
Calvo Villas JM. Calvo Villas JM. Med Clin (Barc). 2019 May 17;152(10):397-404. doi: 10.1016/j.medcli.2018.10.029. Epub 2019 Jan 3. Med Clin (Barc). 2019. PMID: 30612747 Review. English, Spanish.
In patients with hematologic malignancies after cytotoxic therapy or spontaneously and also in advanced solid tumours. Assessment of disease specific risk level for TLS in patients receiving anti-tumoural therapy is essential for early diagnosis. ...Renal rep …
In patients with hematologic malignancies after cytotoxic therapy or spontaneously and also in advanced solid tumours. Assessment of …
Polycystic Kidney/Liver Disease.
Roediger R, Dieterich D, Chanumolu P, Deshpande P. Roediger R, et al. Clin Liver Dis. 2022 May;26(2):229-243. doi: 10.1016/j.cld.2022.01.009. Epub 2022 Apr 1. Clin Liver Dis. 2022. PMID: 35487607 Review.
Though isolated PCLD and PCLD due to ADPKD are genetically distinct, they follow a similar clinical course of hepatomegaly from multiple cysts with preserved liver function. Tolvaptan use in ADPKD can slow down the deterioration of renal function and growth of cy
Though isolated PCLD and PCLD due to ADPKD are genetically distinct, they follow a similar clinical course of hepatomegaly from multiple …
Birt-Hogg-Dubé syndrome: diagnosis and management.
Menko FH, van Steensel MA, Giraud S, Friis-Hansen L, Richard S, Ungari S, Nordenskjöld M, Hansen TV, Solly J, Maher ER; European BHD Consortium. Menko FH, et al. Lancet Oncol. 2009 Dec;10(12):1199-206. doi: 10.1016/S1470-2045(09)70188-3. Lancet Oncol. 2009. PMID: 19959076 Review.
Birt-Hogg-Dube syndrome (BHD) is an autosomal dominant condition characterised clinically by skin fibrofolliculomas, pulmonary cysts, spontaneous pneumothorax, and renal cancer. The condition is caused by germline mutations in the FLCN gene, which encodes folliculin …
Birt-Hogg-Dube syndrome (BHD) is an autosomal dominant condition characterised clinically by skin fibrofolliculomas, pulmonary cysts, …
Polycystic kidney disease: novel insights into polycystin function.
Luo L, Roy S, Li L, Ma M. Luo L, et al. Trends Mol Med. 2023 Apr;29(4):268-281. doi: 10.1016/j.molmed.2023.01.005. Epub 2023 Feb 15. Trends Mol Med. 2023. PMID: 36805211 Review.
Autosomal dominant polycystic kidney disease (ADPKD) is a life-threatening monogenic disease caused by mutations in PKD1 and PKD2 that encode polycystin 1 (PC1) and polycystin 2 (PC2). PC1/2 localize to cilia of renal epithelial cells, and their function is believed to emb …
Autosomal dominant polycystic kidney disease (ADPKD) is a life-threatening monogenic disease caused by mutations in PKD1 and PKD2 that encod …
Ki-67 protein as a tumour proliferation marker.
Menon SS, Guruvayoorappan C, Sakthivel KM, Rasmi RR. Menon SS, et al. Clin Chim Acta. 2019 Apr;491:39-45. doi: 10.1016/j.cca.2019.01.011. Epub 2019 Jan 14. Clin Chim Acta. 2019. PMID: 30653951 Review.
Recent breakthrough discoveries have highlighted the correlation of Ki-67 expression to stage and metastatic potential in renal tumours. A better understanding of molecular structure and different protein domains along with its regulation will provide evidence for p …
Recent breakthrough discoveries have highlighted the correlation of Ki-67 expression to stage and metastatic potential in renal tu
Autosomal Dominant Polycystic Kidney Disease: From Pathophysiology of Cystogenesis to Advances in the Treatment.
Reiterová J, Tesař V. Reiterová J, et al. Int J Mol Sci. 2022 Mar 19;23(6):3317. doi: 10.3390/ijms23063317. Int J Mol Sci. 2022. PMID: 35328738 Free PMC article. Review.
Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic renal disease, with an estimated prevalence between 1:1000 and 1:2500. ...Reduction of calcium ions and induction of cyclic adenosine monophosphate (sAMP) promote cyst enlargement by tra …
Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic renal disease, with an estimated prevalence between 1 …
Birt-Hogg-Dubé Syndrome.
Gupta N, Sunwoo BY, Kotloff RM. Gupta N, et al. Clin Chest Med. 2016 Sep;37(3):475-86. doi: 10.1016/j.ccm.2016.04.010. Epub 2016 Jun 25. Clin Chest Med. 2016. PMID: 27514594 Review.
Birt-Hogg-Dube syndrome (BHD) is a rare autosomal dominant disorder caused by mutations in the Folliculin gene and is characterized by the formation of fibrofolliculomas, early onset renal cancers, pulmonary cysts, and spontaneous pneumothoraces. The exact pathogene …
Birt-Hogg-Dube syndrome (BHD) is a rare autosomal dominant disorder caused by mutations in the Folliculin gene and is characterized by the f …
17,732 results
You have reached the last available page of results. Please see the User Guide for more information.